LON:CTEC

Convatec Group (CTEC) Share Price, News & Analysis

Convatec Group logo
GBX 250 -2.80 (-1.11%)
As of 06:23 AM Eastern

About Convatec Group Stock (LON:CTEC)

Advanced

Key Stats

Today's Range
249.20
▼
252.60
50-Day Range
210.80
▼
257.93
52-Week Range
193
▼
259.80
Volume
16.69 million shs
Average Volume
40.22 million shs
Market Capitalization
£4.78 billion
P/E Ratio
40.32
Dividend Yield
2.15%
Price Target
GBX 305.44
Consensus Rating
Moderate Buy

Company Overview

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Convatec Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

CTEC MarketRank™: 
2.603708149925 of 5 stars

Convatec Group scored higher than 52% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Convatec Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on no strong buy ratings, 8 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Convatec Group has a consensus price target of GBX 305.44, representing about 22.3% upside from its current price of GBX 249.72.

  • Amount of Analyst Coverage

    Convatec Group has only been the subject of 1 research reports in the past 90 days.

  • Read more about Convatec Group's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Convatec Group is 40.28, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.37.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Convatec Group is 40.28, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.71.

  • Price to Earnings Growth Ratio

    Convatec Group has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Convatec Group has a P/B Ratio of 3.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CTEC.
  • Dividend Yield

    Convatec Group pays a meaningful dividend of 2.15%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Convatec Group does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Convatec Group is 116.90%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Convatec Group's dividend.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Convatec Group this week, compared to 0 articles on an average week.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net £56,120 in company stock, which represents 0.0012% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Convatec Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought £56,120 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    1.00% of the stock of Convatec Group is held by insiders.

  • Percentage Held by Institutions

    70.07% of the stock of Convatec Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Convatec Group's insider trading history.
Receive CTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Convatec Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CTEC Stock News Headlines

Convatec Group (LON:CTEC) Stock Jumps 0.6% - Here's What Happened
You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
Convatec non-executive director Viebke buys 24,000 shares
See More Headlines

CTEC Stock Analysis - Frequently Asked Questions

Convatec Group's stock was trading at GBX 243.20 at the beginning of the year. Since then, CTEC stock has increased by 2.7% and is now trading at GBX 249.72.

Convatec Group PLC (LON:CTEC) announced its earnings results on Friday, February, 28th. The company reported GBX 12 EPS for the quarter, missing analysts' consensus estimates of GBX 12.70 by GBX 0.70. Convatec Group had a trailing twelve-month return on equity of 8.40% and a net margin of 4.99%.

Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Convatec Group investors own include Tesla (TSLA), Bristol Myers Squibb (BMY), FedEx (FDX), Eli Lilly and Company (LLY), ConvaTec Group (CNVVY), Barclays (BARC) and Dunelm Group (DNLM).

Company Calendar

Today
11/16/2026
Trading update
11/18/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
LON:CTEC
CIK
N/A
Fax
N/A
Employees
10,000
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 375
Low Price Target
GBX 230
Potential Upside/Downside
+22.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.89
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 6.20
Trailing P/E Ratio
40.26
Forward P/E Ratio
N/A
P/E Growth
0.93
Net Income
£188.35 million
Net Margins
4.99%
Pretax Margin
N/A
Return on Equity
8.40%
Return on Assets
5.01%

Debt

Debt-to-Equity Ratio
121.83
Current Ratio
1.93
Quick Ratio
0.96

Sales & Book Value

Annual Sales
£2.49 billion
Price / Sales
1.92
Cash Flow
GBX 14.68 per share
Price / Cash Flow
17.01
Book Value
GBX 80.01 per share
Price / Book
3.12

Miscellaneous

Outstanding Shares
1,911,833,000
Free Float
N/A
Market Cap
£4.77 billion
Optionable
Not Optionable
Beta
0.77
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (LON:CTEC) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners